cor2ed
engage checkpoint medical linkedin twitter
bg

Is there a difference in liver cancer rates in patients who receive treatment for hepatitis?

Is there a difference in liver cancer rates in patients who receive treatment for hepatitis?

Prof. Sammy Saab

Dr. Sammy Saab discusses the clinical question: Is there a difference in liver cancer rates in patients who receive treatment for hepatitits?
Portrait of Sammy Saab
Prof. Sammy Saab

Gastroenterologist and Transplant Hepatologist

David Geffen School of Medicine, UCLA

United States (US)

preview next

time Expert View | open 5 min | 2018

download resources

I agree that this educational programme:

HCC CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Eisai Europe Limited.

Other programmes of interest

preview next